Galica, Jacqueline
Saunders, Stephanie
Pan, Ziwei
Silva, Amina
Ling, Hok Kan
Article History
Received: 13 September 2023
Accepted: 18 December 2023
First Online: 28 January 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Ethical approval for the primary study was granted by the Women’s College Hospital Research Ethics Board (#2104-005-B) which operates in compliance with the Tri-Council Policy Statement, International Council for Harmonisation/ Good Clinical Practice Guidelines and Part C, Division 5 of the Food and Drug Regulations of Health Canada, Part 4 of the Natural Health Products Regulations, and the Medical Devices Regulations. The secondary analysis was approved for ethical compliance by the Queen's University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (#6029619), which operates in accordance with the ethical principles outlined in the Declaration of Helsinki.
: All participants provided written informed consent.
: Participants in the primary study signed consent indicating that published studies would not reveal their identity. No individual identifiers are contained in this manuscript.